• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Bayer To Lower Cost Of Eylea 2mg In India For Retinal Disease

    INDPHARMAPOST

    Bayer Ditches 1 AAV Gene Therapy From Pompe Disease Pair

    FIERCE BIOTECH

    Essential Pharma Acquires Ventavis to Bolster Pulmonary Portfolio

    GLOBENEWSWIRE

    Genethon Licenses Askbio For Pompe Disease Gene Therapy

    BUSINESSWIRE

    FDA Accepts AskBio IND for AB-1009 in Pompe Disease LOPD

    GLOBENEWSWIRE

    Bayer Initiates Phase 2 Trial For Alport Syndrome Treatment

    PHARMIWEB

    Bayer cuts PhII orphan drug as it ups R&D spending

    ENDPTS

    TG Therapeutics’ shares jump as umbralisib wins FDA’s breakthrough status

    ENDPTS

    Bayer`s hemophilia A treatment gets U.S. FDA approval

    REUTERS

    Novartis farms out rare disease drug to LifeMax Labs

    FIERCE BIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.